Clinical trials
Completed Arthritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
493 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 4 |
| 2002 | 9 |
| 2003 | 13 |
| 2004 | 18 |
| 2005 | 17 |
| 2006 | 22 |
| 2007 | 19 |
| 2008 | 25 |
| 2009 | 35 |
| 2010 | 22 |
| 2011 | 27 |
| 2012 | 20 |
| 2013 | 23 |
| 2014 | 19 |
| 2015 | 26 |
| 2016 | 37 |
| 2017 | 18 |
| 2018 | 20 |
| 2019 | 21 |
| 2020 | 12 |
| 2021 | 14 |
| 2022 | 10 |
| 2023 | 13 |
| 2024 | 10 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 493 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 18 |
| Pfizer | 17 |
| Zimmer Biomet | 16 |
| AbbVie | 14 |
| National Center for Research Resources (NCRR) | 12 |
| Novartis Pharmaceuticals | 10 |
| Sunnybrook Health Sciences Centre | 10 |
| University of British Columbia | 9 |
| Centers for Disease Control and Prevention | 8 |
| Duke University | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis | 493 |
| Arthritis, Rheumatoid | 128 |
| Osteoarthritis | 118 |
| Joint Diseases | 72 |
| Osteoarthritis, Knee | 56 |
| Musculoskeletal Diseases | 45 |
| Rheumatic Diseases | 39 |
| Arthritis, Psoriatic | 35 |
| Pain | 32 |
| Connective Tissue Diseases | 31 |
Trials
Showing 1 to 25 of 493. Each trial links to its page on Pharma Observatory.
393 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.